Recruiting

Observational Study

Sponsor:

Mayo Clinic

Code:

NCT00830557

Conditions

Islet Cell Tumor

Pancreatic Cancer

Pancreatic Disease

Acute Pancreatitis

Chronic Pancreatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

medical chart review

survey administration

biospecimen collection

Study Details

Brief summary:

RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future.

PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders.

Conditions

Islet Cell Tumor

Pancreatic Cancer

Pancreatic Disease

Acute Pancreatitis

Chronic Pancreatitis

Study ID

NCT00830557

Start date

Oct 1, 2000

Status verified date

Mar, 2026

Completion date

Aug 30, 2027

Anticipated

Primary completion date

Aug 30, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

  • Known or suspected pancreas disease including:

  • pancreas adenocarcinoma
  • islet cell cancer
  • pancreatic cysts
  • pancreatitis (hereditary, acute, or chronic)
  • Next of kin of deceased participant who did not complete participation before passing away

Exclusion Criteria:

  • Under the age of 18
  • Unable to provide informed consent
  • Prison inmates

Study Design

Enrollment

20000 participants

Anticipated

Interventions and Outcome Measures

Arms

Observational

Patients undergo blood, saliva, and previously obtained leftover tissue sample collection on study. Patients also complete questionnaires and have their medical records reviewed on study.

Interventions

medical chart review

baseline, 12 month and 36 months

survey administration

baseline, 6 month, 12 month

biospecimen collection

baseline

Primary outcome measure

  • Collection of clinical data, health and family histories by survey [ Time Frame: baseline enrollment, 6 months, 12 months ]
  • Collection of blood and/or tissue, fecal and oral specimens [ Time Frame: baseline ]
  • Collection of information regarding food preparation and intake by survey [ Time Frame: baseline ]

Central Contacts and Locations

Central contacts

Adriana Delgado, MA

800-914-7962pancreas@mayo.edu

Heather M Streich, CCRP

800-914-7962pancreas@mayo.edu

Locations

Mayo Clinic Hospital in Arizona

Recruiting

Phoenix, Arizona, United States, 85054

Contacts

Pancreas Team

480-301-8000pancreas@mayo.edu

Principal Investigator:

Zhi Fong, MD

Mayo Clinic in Florida

Recruiting

Jacksonville, Florida, United States, 32224-9980

Contacts

Pancreas Team

904-953-6970pancreas@mayo.edu

Principal Investigator:

Michael Wallace, MD

Mayo Clinic in Rochester

Recruiting

Rochester, Minnesota, United States, 55905

Contacts

Pancreas Team

800-914-7962pancreas@mayo.edu

Principal Investigator:

Shounak Majumder, MD

More Information

Sponsor

Mayo Clinic

Last update posted

Mar 9, 2026

Last verified

Mar, 2026

Keywords

  • recurrent pancreatic cancer
  • stage I pancreatic cancer
  • stage II pancreatic cancer
  • stage III pancreatic cancer
  • stage IV pancreatic cancer
  • recurrent islet cell carcinoma
  • pancreatic alpha cell carcinoma
  • pancreatic beta islet cell carcinoma
  • pancreatic delta cell carcinoma
  • pancreatic G-cell carcinoma

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-03-09.